Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. (Q50660364)

17 March 2018

title

Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. (English)

1 reference

17 March 2018

1 reference

Kroon FP

1

1 reference

17 March 2018

van Dissel JT

2

1 reference

17 March 2018

de Jong JC

3

1 reference

17 March 2018

Zwinderman K

4

1 reference

17 March 2018

van Furth R

5

1 reference

17 March 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

17 March 2018

published in

Vaccine

1 reference

17 March 2018

volume

18

1 reference

17 March 2018

issue

26

1 reference

17 March 2018

page(s)

3040-3049

1 reference

17 March 2018

Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

B-cell immunodeficiency in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Influenza in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Influenza A pneumonitis in a patient infected with the human immunodeficiency virus (HIV).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Susceptibility to influenza A in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Quantitative analysis of CD4+ T cell function in the course of human immunodeficiency virus infection. Gradual decline of both naive and memory alloreactive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Revised (1972-1973) bivalent influenza vaccine. Serum and nasal antibody responses to parenteral vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Whole-blood lymphocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Antibody Responses After Influenza and Pneumococcal Immunization in HIV-Infected Homosexual Men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Immunogenicity of influenza vaccine (1993–1994 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Antibody response to Haemophilus influenzae type b vaccine in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Poliovirus vaccination responses in HIV-infected patients: correlation with T4 cell counts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Antibody response of an elderly population to a supplemental dose of influenza B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Immune response of adults to sequential influenza vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Relation of chronic disease and immune response to influenza vaccine in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Antibody response to whole-virus and split-virus influenza vaccines in successful ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Effect of immunomodulator thymopentin on impaired seroresponse to influenza vaccine in patients on haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Comparative responses of elderly persons to aqueous and depot influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900079-7

7 January 2021

10.1016/S0264-410X(00)00079-7

Identifiers

DOI

1 reference

17 March 2018

PubMed ID

10825608

1 reference

17 March 2018